- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8547
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,547 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ZVRA | US$7.20 | 4.0% | 53.2% | US$377.8m | US$20.50 | PS16x | E68.5% | n/a | Pharmaceuticals & Biotech | ||
CALTX | SEK 206.60 | 0.2% | 103.1% | SEK 11.2b | SEK 227.50 | PS7x | E50.4% | n/a | Pharmaceuticals & Biotech | ||
AGP | €7.11 | 1.9% | 43.3% | €123.1m | €12.85 | PE18.2x | E22.1% | n/a | Capital Goods | ||
AFISH | NOK 49.00 | 0% | -44.3% | NOK 1.6b | NOK 81.00 | PS1.6x | E98.9% | n/a | Food, Beverage & Tobacco | ||
MBTN | CHF 1.60 | -7.8% | -99.2% | CHF 49.2m | CHF 6.03 | PB0.3x | E95.4% | n/a | Semiconductors | ||
AXSM | US$86.59 | -3.4% | 26.2% | US$4.4b | US$125.29 | PS14.3x | E68.9% | n/a | Pharmaceuticals & Biotech | ||
NVG | zł1.83 | -0.3% | -22.3% | zł63.9m | zł3.65 | PE216.6x | E41.4% | 3.3% | Diversified Financials | ||
ICOP | €6.90 | 10.9% | n/a | €190.7m | €9.30 | PE37.8x | E49.2% | n/a | Capital Goods | ||
CADLR | NOK 75.40 | 3.9% | 114.8% | NOK 26.4b | NOK 81.94 | PS18.4x | E67.8% | n/a | Capital Goods | ||
RHM | €520.00 | 7.8% | 122.4% | €22.6b | €616.44 | PE34.6x | E27.7% | 1.1% | Capital Goods | ||
ARES | US$160.39 | 2.2% | 47.9% | US$49.2b | US$152.69 | PE84.7x | E32.9% | 2.3% | Diversified Financials | ||
NEWBRY | SEK 3.98 | 8.7% | 26.3% | SEK 96.5m | SEK 8.00 | PS5.2x | E116.2% | n/a | Pharmaceuticals & Biotech | ||
MVW | NOK 10.30 | 0% | 31.0% | NOK 337.0m | NOK 12.20 | PS19.6x | E70.8% | n/a | Materials | ||
RDUE | €8.70 | -2.2% | -4.4% | €54.4m | €12.55 | PE16x | E35.7% | 2.6% | Capital Goods | ||
TGTX | US$22.23 | -6.7% | 185.7% | US$3.2b | US$33.75 | PE33.3x | E43.5% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | SEK 1.12 | -8.7% | -8.1% | SEK 303.2m | SEK 2.20 | PS2.6x | E86.1% | n/a | Tech | ||
AESI | US$22.71 | 6.1% | 6.6% | US$2.5b | US$25.91 | PE17.1x | E42.1% | 4.1% | Energy | ||
SCOL | SEK 0.14 | -11.1% | -91.4% | SEK 31.5m | n/a | PB0.7x | E75.3% | n/a | Pharmaceuticals & Biotech | ||
TVTX | US$15.23 | 8.7% | 100.4% | US$1.0b | US$17.00 | PS6.6x | E69.3% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$32.57 | 3.6% | 88.8% | US$5.1b | US$35.33 | PS24.9x | E95.0% | n/a | Semiconductors | ||
FWRY | ج.م8.50 | 1.6% | 82.0% | ج.م29.0b | ج.م11.44 | PE30.1x | E29.4% | n/a | Diversified Financials | ||
RMDA | ج.م3.14 | 14.2% | 124.6% | ج.م4.7b | ج.م4.11 | PE20.8x | E30.2% | 2.1% | Pharmaceuticals & Biotech | ||
NVDA | US$124.92 | 2.9% | 173.0% | US$3.1t | US$149.86 | PE57.8x | E22.4% | 0.03% | Semiconductors | ||
LAVV3 | R$8.08 | 1.0% | 17.3% | R$1.6b | R$12.98 | PE5.8x | E21.1% | 3.5% | Real Estate Management and Development |